(Total Views: 492)
Posted On: 07/27/2021 5:15:34 PM
Post# of 153831
Here's a very comprehensive article on PASC with a brief mention of the leronlimab long hauler trial.
https://www.bmj.com/content/374/bmj.n1648
"Other potential treatments are molecules that suppress the intense inflammatory response seen in covid-19. Leronlimab is a monoclonal antibody that blocks the function of CCL-5. It has been shown to be effective and safe in HIV and reduces plasma interleukin-6 levels in covid-19. Clinical trials are ongoing to evaluate the efficacy of leronlimab post-covid-19 (NCT04343651, NCT04347239, NCT04678830)."
https://www.bmj.com/content/374/bmj.n1648
"Other potential treatments are molecules that suppress the intense inflammatory response seen in covid-19. Leronlimab is a monoclonal antibody that blocks the function of CCL-5. It has been shown to be effective and safe in HIV and reduces plasma interleukin-6 levels in covid-19. Clinical trials are ongoing to evaluate the efficacy of leronlimab post-covid-19 (NCT04343651, NCT04347239, NCT04678830)."
(9)
(0)
